ARTIVION INC (AORT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AORT - US2289031005 - Common Stock
45.83 USD
-0.83 (-1.78%)
44.86 USD
-0.97 (-2.12%)
We assign a fundamental rating of 5 out of 10 to AORT. AORT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. AORT has an average financial health and profitability rating. AORT has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year AORT has reported negative net income.
In the past year AORT had a positive cash flow from operations.
AORT had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AORT reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.06%, AORT is in the better half of the industry, outperforming 71.28% of the companies in the same industry.
AORT's Return On Equity of -2.08% is fine compared to the rest of the industry. AORT outperforms 71.81% of its industry peers.
AORT has a Return On Invested Capital of 2.28%. This is in the better half of the industry: AORT outperforms 69.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROIC | 2.28% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AORT has a better Operating Margin (5.26%) than 70.21% of its industry peers.
AORT's Operating Margin has improved in the last couple of years.
AORT has a Gross Margin of 64.50%. This is in the better half of the industry: AORT outperforms 65.43% of its industry peers.
AORT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% |
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AORT is destroying value.
Compared to 1 year ago, AORT has more shares outstanding
The number of shares outstanding for AORT has been increased compared to 5 years ago.
Compared to 1 year ago, AORT has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.95 indicates that AORT is not in any danger for bankruptcy at the moment.
The Altman-Z score of AORT (3.95) is better than 73.40% of its industry peers.
The Debt to FCF ratio of AORT is 12.48, which is on the high side as it means it would take AORT, 12.48 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.48, AORT is in the better half of the industry, outperforming 71.28% of the companies in the same industry.
A Debt/Equity ratio of 0.50 indicates that AORT is not too dependend on debt financing.
AORT has a Debt to Equity ratio (0.50) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Altman-Z | 3.95 |
ROIC/WACC0.27
WACC8.34%
2.3 Liquidity
AORT has a Current Ratio of 3.93. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.93, AORT is in the better half of the industry, outperforming 69.68% of the companies in the same industry.
AORT has a Quick Ratio of 2.88. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.88, AORT is in the better half of the industry, outperforming 65.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 |
3. Growth
3.1 Past
AORT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.71%.
The Revenue has grown by 9.81% in the past year. This is quite good.
Measured over the past years, AORT shows a small growth in Revenue. The Revenue has been growing by 7.06% on average per year.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
3.2 Future
Based on estimates for the next years, AORT will show a very strong growth in Earnings Per Share. The EPS will grow by 46.17% on average per year.
Based on estimates for the next years, AORT will show a quite strong growth in Revenue. The Revenue will grow by 11.94% on average per year.
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.17%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.94%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AORT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 113.30 indicates a quite expensive valuation of AORT.
Based on the Price/Forward Earnings ratio, AORT is valued a bit cheaper than 64.89% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AORT to the average of the S&P500 Index (36.21), we can say AORT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 113.3 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 67.02% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 68.62% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 124.06 | ||
| EV/EBITDA | 51.21 |
4.3 Compensation for Growth
AORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AORT's earnings are expected to grow with 51.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.48%
EPS Next 3Y51.07%
5. Dividend
5.1 Amount
No dividends for AORT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
45.83
-0.83 (-1.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners84.01%
Inst Owner ChangeN/A
Ins Owners4.41%
Ins Owner Change-6.08%
Market Cap2.17B
Revenue(TTM)422.65M
Net Income(TTM)-9.12M
Analysts83.08
Price Target52.75 (15.1%)
Short Float %3.27%
Short Ratio3.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1085.72%
Min EPS beat(2)243.19%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)431.47%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)6
Avg EPS beat(8)226.74%
EPS beat(12)8
Avg EPS beat(12)127.86%
EPS beat(16)11
Avg EPS beat(16)63.37%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.6%
PT rev (1m)18.38%
PT rev (3m)24.06%
EPS NQ rev (1m)22.44%
EPS NQ rev (3m)-14.17%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.52%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 113.3 | ||
| P/S | 5.14 | ||
| P/FCF | 124.06 | ||
| P/OCF | 71.28 | ||
| P/B | 4.95 | ||
| P/tB | 77.93 | ||
| EV/EBITDA | 51.21 |
EPS(TTM)-0.26
EYN/A
EPS(NY)0.4
Fwd EY0.88%
FCF(TTM)0.37
FCFY0.81%
OCF(TTM)0.64
OCFY1.4%
SpS8.92
BVpS9.26
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROCE | 2.88% | ||
| ROIC | 2.28% | ||
| ROICexc | 2.52% | ||
| ROICexgc | 6.11% | ||
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% | ||
| FCFM | 4.14% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 56.35% | ||
| Cap/Sales | 3.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 67.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 | ||
| Altman-Z | 3.95 |
F-Score5
WACC8.34%
ROIC/WACC0.27
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.17%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.94%
EBIT growth 1Y-25.58%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year112.29%
EBIT Next 3Y43.08%
EBIT Next 5Y34.17%
FCF growth 1Y4464.09%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y292.01%
OCF growth 3YN/A
OCF growth 5Y7.04%
ARTIVION INC / AORT FAQ
Can you provide the ChartMill fundamental rating for ARTIVION INC?
ChartMill assigns a fundamental rating of 5 / 10 to AORT.
Can you provide the valuation status for ARTIVION INC?
ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.
Can you provide the profitability details for ARTIVION INC?
ARTIVION INC (AORT) has a profitability rating of 4 / 10.
Can you provide the financial health for AORT stock?
The financial health rating of ARTIVION INC (AORT) is 6 / 10.